Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).
about
Efficacy and safety of vinorelbine plus cisplatin chemotherapy for patients with recurrent and/or metastatic salivary gland cancer of the head and neck.Personalized oncogenomic analysis of metastatic adenoid cystic carcinoma: using whole-genome sequencing to inform clinical decision-making.Nintedanib inhibits growth of human prostate carcinoma cells by modulating both cell cycle and angiogenesis regulators.
P2860
Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Clinical trial of nintedanib i ...... n Cancer Study Group HN14-01).
@en
Clinical trial of nintedanib i ...... k: A multicenter phase 2 study
@nl
type
label
Clinical trial of nintedanib i ...... n Cancer Study Group HN14-01).
@en
Clinical trial of nintedanib i ...... k: A multicenter phase 2 study
@nl
prefLabel
Clinical trial of nintedanib i ...... n Cancer Study Group HN14-01).
@en
Clinical trial of nintedanib i ...... k: A multicenter phase 2 study
@nl
P2093
P2860
P356
P1433
P1476
Clinical trial of nintedanib i ...... an Cancer Study Group HN14-01)
@en
P2093
Bhumsuk Keam
Eun Joo Kang
Ha-Young Lee
Ho Jung An
Hye Ryun Kim
Ji Yun Lee
Jinsoo Kim
Jong-Mu Sun
Keunchil Park
Ki Hyeong Lee
P2860
P304
P356
10.1002/CNCR.30537
P407
P50
P577
2017-01-19T00:00:00Z